At the end of Q1 2025, 24 institutions reported holding TNF Pharmaceuticals Inc. in their 13F filings, down 1 from Q4 2024. 3 opened new positions and 3 sold out. The largest holders were Morgan Stanley ($36K), Geode Capital Management, LLC ($10K) and CreativeOne Wealth, LLC ($8K).
Company
TNF Pharmaceuticals Inc.
CUSIP
62856X201
Latest filing quarter
Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
Institutions
Total Value
New Positions
3
$15K
Exits
3
$27K
All 13F filers, Q4 2024 → Q1 2025: 94,551 shares bought and 24,055 shares sold, net +70,496 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.